<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Wed, 14 Feb 2024 16:28:34 -0500--><rss version="2.0">
    <channel>
        <title>Nighthawk Biosciences, Inc. (SCPX) SEC Filings</title>
        <link>https://www.nighthawkbio.com/investors-news/sec-filings/quarterly-reports/rss</link>
        <description>Nighthawk Biosciences, Inc. (SCPX) - Quarterly Reports</description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/nighthawkbio/files/theme/images/logo-sm.png</url>
                <title>Nighthawk Biosciences, Inc. Logo</title>
                <link>/investors-news</link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[10-Q - Quarterly report pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://www.nighthawkbio.com/investors-news/sec-filings/all-sec-filings/content/0001558370-23-019242/0001558370-23-019242.pdf</link>
                <pubDate>Mon, 20 Nov 23 16:02:57 -0500</pubDate>
                <guid>https://www.nighthawkbio.com/investors-news/sec-filings/all-sec-filings/content/0001558370-23-019242/0001558370-23-019242.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[NT 10-Q - Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB]]></title>
                <description><![CDATA[NT 10-Q]]></description>
                <link>https://www.nighthawkbio.com/investors-news/sec-filings/all-sec-filings/content/0001558370-23-019092/0001558370-23-019092.pdf</link>
                <pubDate>Wed, 15 Nov 23 13:11:19 -0500</pubDate>
                <guid>https://www.nighthawkbio.com/investors-news/sec-filings/all-sec-filings/content/0001558370-23-019092/0001558370-23-019092.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://www.nighthawkbio.com/investors-news/sec-filings/all-sec-filings/content/0001558370-23-014848/0001558370-23-014848.pdf</link>
                <pubDate>Mon, 14 Aug 23 16:42:51 -0400</pubDate>
                <guid>https://www.nighthawkbio.com/investors-news/sec-filings/all-sec-filings/content/0001558370-23-014848/0001558370-23-014848.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://www.nighthawkbio.com/investors-news/sec-filings/all-sec-filings/content/0001558370-23-009863/0001558370-23-009863.pdf</link>
                <pubDate>Mon, 15 May 23 16:34:35 -0400</pubDate>
                <guid>https://www.nighthawkbio.com/investors-news/sec-filings/all-sec-filings/content/0001558370-23-009863/0001558370-23-009863.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://www.nighthawkbio.com/investors-news/sec-filings/all-sec-filings/content/0001558370-22-017784/0001558370-22-017784.pdf</link>
                <pubDate>Mon, 14 Nov 22 16:55:10 -0500</pubDate>
                <guid>https://www.nighthawkbio.com/investors-news/sec-filings/all-sec-filings/content/0001558370-22-017784/0001558370-22-017784.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://www.nighthawkbio.com/investors-news/sec-filings/all-sec-filings/content/0001558370-22-013065/0001558370-22-013065.pdf</link>
                <pubDate>Wed, 10 Aug 22 17:00:36 -0400</pubDate>
                <guid>https://www.nighthawkbio.com/investors-news/sec-filings/all-sec-filings/content/0001558370-22-013065/0001558370-22-013065.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://www.nighthawkbio.com/investors-news/sec-filings/all-sec-filings/content/0001558370-22-008995/0001558370-22-008995.pdf</link>
                <pubDate>Mon, 16 May 22 17:26:16 -0400</pubDate>
                <guid>https://www.nighthawkbio.com/investors-news/sec-filings/all-sec-filings/content/0001558370-22-008995/0001558370-22-008995.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://www.nighthawkbio.com/investors-news/sec-filings/all-sec-filings/content/0001558370-21-015504/0001558370-21-015504.pdf</link>
                <pubDate>Mon, 14 Mar 22 16:29:34 -0400</pubDate>
                <guid>https://www.nighthawkbio.com/investors-news/sec-filings/all-sec-filings/content/0001558370-21-015504/0001558370-21-015504.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[9 Related Documents: 10-Q, EX-10.2, EX-10.3, EX-10.4, EX-10.5, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://www.nighthawkbio.com/investors-news/sec-filings/all-sec-filings/content/0001558370-21-011303/0001558370-21-011303.pdf</link>
                <pubDate>Mon, 14 Mar 22 16:29:02 -0400</pubDate>
                <guid>https://www.nighthawkbio.com/investors-news/sec-filings/all-sec-filings/content/0001558370-21-011303/0001558370-21-011303.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q/A - Quarterly report pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[3 Related Documents: 10-Q/A, EX-31.1, EX-31.2]]></description>
                <link>https://www.nighthawkbio.com/investors-news/sec-filings/all-sec-filings/content/0001558370-21-007279/0001558370-21-007279.pdf</link>
                <pubDate>Mon, 14 Mar 22 16:28:57 -0400</pubDate>
                <guid>https://www.nighthawkbio.com/investors-news/sec-filings/all-sec-filings/content/0001558370-21-007279/0001558370-21-007279.pdf</guid>
                                                                            </item>
            </channel>
</rss>